AMT-116 in Combination With AK112 in Patients With Lung Cancer
Clinical trial NCT07590531 · RECRUITING
Trial details
- NCT number
- NCT07590531
- Sponsor
- Multitude Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2027-05-30
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.